Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arcturus Therapeutics Holdings Inc shares valued at $249,121 were sold by Chivukula Pad on Oct 15 ’24. At $20.76 per share, Chivukula Pad sold 12,000 shares. The insider’s holdings dropped to 435,334 shares worth approximately $7.62 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Chivukula Pad purchased 12,000 shares, netting a total of over 249,121 in proceeds.
Before that, SASSINE ANDY had sold 50,000 shares from its account. In a trade valued at $1,601,500, the Chief Financial Officer traded Arcturus Therapeutics Holdings Inc shares for $32.03 each. Upon closing the transaction, the insider’s holdings decreased to 50,000 shares, worth approximately $3.86 million.
As published in their initiating research note from Leerink Partners on August 12, 2024, Arcturus Therapeutics Holdings Inc [ARCT] has been an Outperform and the price target has been revised to $70. Analysts at Canaccord Genuity started covering the stock with ‘”a Buy”‘ outlook in a report released in mid December. As of July 24, 2023, William Blair has initiated its “an Outperform” rating for ARCT. Earlier on May 11, 2023, H.C. Wainwright upgraded its rating. Their new recommendation was “a Buy” for ARCT stock which previously was a “a Neutral”.
Analyzing ARCT Stock Performance
During the last five days, there has been a surge of approximately 8.29%. Over the course of the year, Arcturus Therapeutics Holdings Inc shares have dropped approximately -44.47%. Shares of the company reached a 52-week high of $45.00 on 06/05/24 and a 52-week low of $14.93 on 11/15/24. A 50-day SMA is recorded $20.02, while a 200-day SMA reached $26.23. Nevertheless, trading volume fell to 0.23 million shares from 0.6 million shares the previous day.
Support And Resistance Levels for Arcturus Therapeutics Holdings Inc (ARCT)
According to the 24-hour chart, there is a support level at 17.05, which, if violated, would cause prices to drop to 16.59. In the upper region, resistance lies at 17.84. The next price resistance is at 18.18. RSI (Relative Strength Index) is 45.65 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.49, which suggests the price will decrease in the coming days. Percent R is at 61.38%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
